Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04210245
Recruitment Status : Recruiting
First Posted : December 24, 2019
Last Update Posted : April 1, 2021
Sponsor:
Information provided by (Responsible Party):
NGM Biopharmaceuticals, Inc

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2022
Estimated Study Completion Date : September 2022